The mammalian Rad51 protein is involved in homologous recombination and in DNA damage repair. Its nuclear distribution after DNA damage is highly dynamic, and distinct foci of Rad51 protein, distributed throughout the nuclear volume, are induced within a few hours after γ irradiation; these foci then coalesce into larger clusters. Rad51-positive cells do not undergo DNA replication. Rad51 foci colocalize with both replication protein A and sites of unscheduled DNA repair synthesis and may represent a nuclear domain for recombinational DNA repair. By 24 h postirradiation, most foci are sequestered into micronuclei or assembled into Rad51-coated DNA fibers. These micronuclei and DNA fibers display genome fragmentation typical of apoptotic cell death. Other repair proteins, such as Rad52 and Gadd45, are not eliminated from the nucleus. DNA double strand breaks in repair-deficient cells or induced by the clastogen etoposide are also accompanied by the sequestering of Rad51 protein before cell death. The spindle poison colcemid causes cell cycle arrest and Rad51-foci formation without directly damaging DNA. Collectively, these observations suggest that mammalian Rad51 protein associates with damaged DNA and/or with DNA that is temporarily or irreversibly unable to replicate and these foci may subsequently be eliminated from the nucleus.
Skip Nav Destination
Article navigation
11 January 1999
Article|
January 11 1999
Sequestration of Mammalian Rad51-Recombination Protein into Micronuclei
Thomas Haaf,
Thomas Haaf
*Max-Planck-Institute of Molecular Genetics, 14195 Berlin, Germany; ‡Pangene Corporation, Menlo Park, California 94025; and §Department of Genetics, Yale University School of Medicine, New Haven, Connecticut 06520
Search for other works by this author on:
Elke Raderschall,
Elke Raderschall
*Max-Planck-Institute of Molecular Genetics, 14195 Berlin, Germany; ‡Pangene Corporation, Menlo Park, California 94025; and §Department of Genetics, Yale University School of Medicine, New Haven, Connecticut 06520
Search for other works by this author on:
Gurucharan Reddy,
Gurucharan Reddy
*Max-Planck-Institute of Molecular Genetics, 14195 Berlin, Germany; ‡Pangene Corporation, Menlo Park, California 94025; and §Department of Genetics, Yale University School of Medicine, New Haven, Connecticut 06520
Search for other works by this author on:
David C. Ward,
David C. Ward
*Max-Planck-Institute of Molecular Genetics, 14195 Berlin, Germany; ‡Pangene Corporation, Menlo Park, California 94025; and §Department of Genetics, Yale University School of Medicine, New Haven, Connecticut 06520
Search for other works by this author on:
Charles M. Radding,
Charles M. Radding
*Max-Planck-Institute of Molecular Genetics, 14195 Berlin, Germany; ‡Pangene Corporation, Menlo Park, California 94025; and §Department of Genetics, Yale University School of Medicine, New Haven, Connecticut 06520
Search for other works by this author on:
Efim I. Golub
Efim I. Golub
*Max-Planck-Institute of Molecular Genetics, 14195 Berlin, Germany; ‡Pangene Corporation, Menlo Park, California 94025; and §Department of Genetics, Yale University School of Medicine, New Haven, Connecticut 06520
Search for other works by this author on:
Thomas Haaf
*Max-Planck-Institute of Molecular Genetics, 14195 Berlin, Germany; ‡Pangene Corporation, Menlo Park, California 94025; and §Department of Genetics, Yale University School of Medicine, New Haven, Connecticut 06520
Elke Raderschall
*Max-Planck-Institute of Molecular Genetics, 14195 Berlin, Germany; ‡Pangene Corporation, Menlo Park, California 94025; and §Department of Genetics, Yale University School of Medicine, New Haven, Connecticut 06520
Gurucharan Reddy
*Max-Planck-Institute of Molecular Genetics, 14195 Berlin, Germany; ‡Pangene Corporation, Menlo Park, California 94025; and §Department of Genetics, Yale University School of Medicine, New Haven, Connecticut 06520
David C. Ward
*Max-Planck-Institute of Molecular Genetics, 14195 Berlin, Germany; ‡Pangene Corporation, Menlo Park, California 94025; and §Department of Genetics, Yale University School of Medicine, New Haven, Connecticut 06520
Charles M. Radding
*Max-Planck-Institute of Molecular Genetics, 14195 Berlin, Germany; ‡Pangene Corporation, Menlo Park, California 94025; and §Department of Genetics, Yale University School of Medicine, New Haven, Connecticut 06520
Efim I. Golub
*Max-Planck-Institute of Molecular Genetics, 14195 Berlin, Germany; ‡Pangene Corporation, Menlo Park, California 94025; and §Department of Genetics, Yale University School of Medicine, New Haven, Connecticut 06520
Address correspondence to T. Haaf, Max-Planck-Institute of Molecular Genetics, Ihnestrasse 73, 14195 Berlin, Germany. Tel.: (49) 30 8413 1251. Fax: (49) 30 8413 1383. E-mail: [email protected]
Received:
August 07 1997
Revision Received:
November 15 1998
Online ISSN: 1540-8140
Print ISSN: 0021-9525
1999
J Cell Biol (1999) 144 (1): 11–20.
Article history
Received:
August 07 1997
Revision Received:
November 15 1998
Citation
Thomas Haaf, Elke Raderschall, Gurucharan Reddy, David C. Ward, Charles M. Radding, Efim I. Golub; Sequestration of Mammalian Rad51-Recombination Protein into Micronuclei . J Cell Biol 11 January 1999; 144 (1): 11–20. doi: https://doi.org/10.1083/jcb.144.1.11
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement
Advertisement